Fact Sheet/Brochure

This infographic offers individual-, organization-, and systems-level recommendations for addressing disparities and increasing access to and engagement with tobacco treatment and care for African Americans.

This two-page pocket guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This brochure gives an overview of the Mental Health Parity and Addiction Equity Act of 2008. It lists some of the common limits placed on mental health and substance use disorder benefits and services.

This fact sheet includes several tips for suggesting that a loved one receive treatment for substance use.

This fact sheet includes a basic description of the overdose reversal medication, naloxone. It addresses who should carry it, how to recognize and overdose, and what to do if an overdose is suspected.

This fact sheet includes basic descriptions of medications for opioid use disorders (MOUD) including naltrexone, buprenorphine, and methadone. It also addresses how MOUD can help those struggling with opioid use disorder, misunderstandings about MOUD, and additional considerations.

This fact sheet includes a basic description of opioids, a brief explanation of the risks, ways to prevent misuse, and strategies to helped loved ones who may be struggling with substance use disorder.

This fact sheet includes a basic description of stimulants, a brief explanation of the risks, ways to prevent misuse, and strategies to helped loved ones who may be struggling with substance use disorder.

This fact sheet includes a basic description of fentanyl, a brief explanation of the danger, and strategies to helped loved ones who may be using or at risk of using fentanyl.

This letter announces details on the 2023 Medication Access and Training Expansion (MATE) Act which requires new or renewing DEA licensees to have completed a total of at least eight hours of training on opioid or other substance use disorders and the appropriate treatment of pain.